Page 387 - Nil Nidli - Zakoni zdravlja i izlečenja

386 ZAKONI ZDRAVLJA I IZLEČENJA
Champaign, IL: American Oil Chemists’ Society, 1983 p. 919- 94 Bloch AS, Shils ME. Appendix: Table A-43a. In: Shils ME, Young
933. VR, editors. Modern Nutrition in Health and Disease—7th edi-
68 Peng SK, Taylor CB. Atherogenic Effect of Oxidized Cholesterol. tion. Philadelphia, PA: Lea and Febiger, 1988 p. 1629.
In: Perkins EG, Visek WJ, editors. Dietary Fats and Health. 95 Isselbacher KJ, Braunwald E, editors, et al. Atherosclerosis and
Champaign, IL: American Oil Chemists’ Society, 1983 p. 930. Other Forms of Arteriosclerosis. In Harrison’s Principles of
69 Black CJ. The Ministry of Healing. Nampa, ID: Pacific Press Internal Medicine—13th edition (CD-ROM). New York, NY:
Publishing Association, 1905 p. 301. McGRAW-HILL, Inc. Health Professions Division, 1994 p. 1106-
70 Kosykh VA, Lankin VZ, et al. Very low density lipoprotein secre- 1116.
tion by cultured hepatocytes of rabbits fed purified or autoxi- 96 Williams PT. High-density lipoprotein cholesterol and other risk
dized cholesterol. Lipids 1989 Feb;24(2):109-115. factors for coronary heart disease in female runners. N Engl J
71 Peng SK, Taylor CB. Atherogenic Effect of Oxidized Cholesterol. Med 1996 May 16;334(20):1298-1303.
In: Perkins EG, Visek WJ, editors. Dietary Fats and Health. 97 Blair SN, Kohl HW 3rd, et al. Changes in physical fitness and all-
Champaign, IL: American Oil Chemists’ Society, 1983 p. 919- cause mortality. A prospective study of healthy and unhealthy
933. men. JAMA 1995 Apr 12;273(14):1093-1098.
72 Stamler J, Shekelle R. Dietary cholesterol and human coronary 98 Blair SN, Kohl HW 3rd, et al. Changes in physical fitness and all-
heart disease. The epidemiologic evidence. Arch Pathol Lab Med cause mortality. A prospective study of healthy and unhealthy
1988 Oct;112(10):1032-1040. men. JAMA 1995 Apr 12;273(14):1093-1098.
73 Peng SK, Taylor CB. Atherogenic Effect of Oxidized Cholesterol. 99 Glueck CJ. Nonpharmacologic and pharmacologic alteration of
In: Perkins EG, Visek WJ, editors. Dietary Fats and Health. high-density lipoprotein cholesterol: therapeutic approaches to
Champaign, IL: American Oil Chemists’ Society, 1983 p. 919- prevention of atherosclerosis. Am Heart J 1985
933. Nov;110(5):1107-1115.
74 Colaco CA, Roser BJ. Atherosclerosis and glycation. Bioessays 100 Anzalone DA, Anzalone FL, Fos PJ. High-density lipoprotein-
1994 Feb;16(2):145-147. cholesterol: determining hygienic factors for intervention. J
75 Salonen JT, Nyyssonen K, et al. High stored iron levels are asso- Occup Environ Med 1995 Jul;37(7):856-861.
ciated with excess risk of myocardial infarction in eastern Finnish 101 Glueck CJ. Nonpharmacologic and pharmacologic alteration of
men. Circulation 1992 Sep;86(3):803-811. high-density lipoprotein cholesterol: therapeutic approaches to
76 Ascherio A, Willett WC, et al. Dietary iron intake and risk of coro- prevention of atherosclerosis. Am Heart J 1985
nary disease among men. Circulation 1994 Mar;89(3):969-974. Nov;110(5):1107-1115.
77 Rimm EB, Stampfer MJ, et al. Vitamin E consumption and the 102 American Heart Association. 1997 Heart and Stroke Statistical
risk of coronary heart disease in men. N Engl J Med 1993 May Update. American Heart Association, 1997 p. 3.
20;328(20):1450-1456. 103 Hartung GH, Foreyt JP et al Effect of alcohol intake on high-
78 Nutrition Essentials and Diet Therapy—6th edition. Philadelphia, density lipoprotein cholesterol levels in runners and inactive
PA: W.B. Saunders Co., 1991 p. 106. men. JAMA 1983 Feb 11;249(6):747-750.
79 Nutrition Essentials and Diet Therapy—6th edition. Philadelphia, 104 Gibbons LW, Mitchell TL. HDL Cholesterol and Exercise. Your
PA: W.B. Saunders Co., 1991 p. 100. Patient & Fitness 1995 July 16-August;9(4):6-13.
80 Gaziano JM, Hennekens CH. The role of beta-carotene in the 105 Bordia A. Effect of garlic on blood lipids in patients with coro-
prevention of cardiovascular disease. Ann N Y Acad Sci 1993 nary heart disease. Am J Clin Nutr 1981 Oct;34(10):2100-2103.
Dec 31;691():148-155. Presented at the American College of 106 Willett WC, Manson JE, et al. Weight, weight change, and coro-
Cardiology. Dallas, TX, 1992. nary heart disease in women. Risk within the ‘normal’ weight
81 Greenberg ER , Baron JA, et al. Mortality associated with low range. JAMA 1995 Feb 8;273(6):461-465.
plasma concentration of beta-carotene and the effect of oral 107 Oster G, Epstein AM. Cost-effectiveness of antihyperlipemic
supplementation. JAMA 1996 Mar 6;275(9):699-703. therapy in the prevention of coronary heart disease. The case of
82 Selhub J, Jacques PF, et al. Association between plasma homo- cholestyramine. JAMA 1987 Nov 6;258(17):2381-2387.
cysteine concentrations and extracranial carotid artery stenosis. 108 Jacobs S. American Heart Association Meeting, 1992.
N Engl J Med 1995 Feb 2;332(5):286-291. 109 Mittleman M, Muller J. 1994 Harvard Medical School, Reported
83 Naurath HJ, Joosten E, et al. Effects of vitamin B12, folate, and at the American Heart Association Meeting.
vitamin B6 supplements in elderly people with normal serum 110 Berkman LF, Leo-Summers L, Horwitz RI. Emotional support
vitamin concentrations. Lancet 1995 Jul 8;346(8967):85-89. and survival after myocardial infarction. A prospective, popula-
84 Stampfer MJ, Malinow MR. Can lowering homocysteine levels tion-based study of the elderly. Ann Intern Med 1992 Dec
reduce cardiovascular risk? N Engl J Med 1995 Feb 15;117(12):1003-1009.
2;332(5):328-329. 111 Thorogood M, Cowen P, et al. Fatal myocardial infarction and
85 Stampfer MJ, Malinow MR. Can lowering homocysteine levels use of psychotropic drugs in young women. Lancet 1992 Oct
reduce cardiovascular risk? N Engl J Med 1995 Feb 31;340(8827):1067-1068.
2;332(5):328-329. 112 American Heart Association. 1997 Heart and Stroke Statistical
86 Verhoef P, Kok FJ, et al. Plasma total homocysteine, B vitamins, Update. American Heart Association, 1997 p. 3.
and risk of coronary atherosclerosis. Arterioscler Thromb Vasc 113 Johnson CL, Rifkind BM, et al. Declining serum total cholesterol
Biol 1997 May;17(5):989-995. levels among US adults. The National Health and Nutrition
87 Graham IM, Daly LE, et al. Plasma homocysteine as a risk fac- Examination Surveys. JAMA 1993 Jun 16;269(23):3002-3008.
tor for vascular disease. The European Concerted Action Project. 114 American Heart Association. 1997 Heart and Stroke Statistical
JAMA 1997 Jun 11;277(22):1775-1781. Update. American Heart Association, 1997 p. 2.
88 Nyg~ard O, Refsum H, et al. Coffee consumption and plasma 115 The Harvard Health Letter, 1992.
total homocysteine: The Hordaland Homocysteine Study. Am J 116 Sacks FM, Pfeffer MA, et al. The Effect of Pravastatin on
Clin Nutr 1997 Jan;65(1):136-143. Coronary Events after Myocardial Infarction in Patients with
89 Hall J. University of British Columbia, Genetics Meeting at the Average Cholesterol Levels. N Engl J Med 1996 Oct
Jackson Laboratory in Bar Harbor, Maine, July 24, 1995. 3;335(14):1001-1009.
90 Stampfer MJ, Rimm EB. Folate and cardiovascular disease. Why 117 Bennett, H. Personal Communication. Adventist Health Study;
we need a trial now?. JAMA 1996 Jun 26;275(24):1929-1230. Loma Linda University School of Public Health. August 1996.
91 The Food Processor for Windows: Nutrition Analysis & Fitness 118 Phillips RL, Lemon FR, et al. Coronary heart disease mortality
Software [computer program]. ESHA Research. Salem, Oregon. among Seventh-Day Adventists with differing dietary habits: a
92 The Food Processor for Windows: Nutrition Analysis & Fitness preliminary report. Am J Clin Nutr 1978 Oct;31(10 Suppl):S191-
Software [computer program]. ESHA Research. Salem, Oregon. S198.
93 Elsas LJ 2nd, Acosta PB. Nutrition Support of Inherited Metabolic 119 American Heart Association. 1997 Heart and Stroke Statistical
Diseases. In: Shils ME, Young VR, editors. Modern Nutrition in Update. American Heart Association, 1997 p. 2.
Health and Disease—7th edition. Philadelphia, PA: Lea and 120 Medical Tribune, Cardiology section, Mar 23, 1995, p. 5.
Febiger, 1988 p. 1363-1367.